AstraZeneca-MedImmune Venture Fund Overview

  • Fund Strategy
  • Venture

  • Fund Status
  • Liquidated

  • Size
  • $400M

  • Dry Powder

AstraZeneca-MedImmune Venture Fund General Information

Description

AstraZeneca-MedImmune Venture Fund was a venture capital fund managed by MedImmune Ventures. The fund was located in Gaithersburg, Maryland.

Contact Information

Fund Manager
Fund Manager Website
Fund Category
Venture Capital
Native Currency
USD
Fund Manager's Location
  • One MedImmune Way
  • Gaithersburg, MD 20878
  • United States
Fund Domiciles
United States

AstraZeneca-MedImmune Venture Fund Investments (21)

AstraZeneca-MedImmune Venture Fund has made a total of 21 investments. Its most recent deal was a with G1 Therapeutics for . The deal was made on 01-Jul-2016.

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
G1 Therapeutics 01-Jul-2016 Drug Discovery Clinical Trials - Phase 2
G1 Therapeutics 05-Feb-2015 Drug Discovery Clinical Trials - Phase 1
Astria Therapeutics 15-Nov-2013 Drug Discovery Generating Revenue
G1 Therapeutics 16-Oct-2013 Drug Discovery Startup
Inotek Pharmaceuticals 27-Sep-2013 Drug Discovery Clinical Trials - General
Astria Therapeutics 27-Jun-2013 Drug Discovery Generating Revenue
Cerapedics 12-Dec-2012 Surgical Devices Generating Revenue
Astria Therapeutics 10-Jul-2012 Drug Discovery Generating Revenue
Armaron Bio 05-Dec-2011 Early Stage VC Biotechnology Clinical Trials - Phase 1
Inotek Pharmaceuticals 11-Jun-2010 Later Stage VC (Series D) Drug Discovery Clinical Trials - General
You’re viewing 10 of 21 investments. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AstraZeneca-MedImmune Venture Fund Investment Strategy

Investments by Industry

Investments by Deal Type

PitchBook helps you see a fund’s investments based on target industry, year and deal type—so you can quickly understand its strategy at a glance.

Request a free trial

AstraZeneca-MedImmune Venture Fund Limited Partners (1)

AstraZeneca Defined Benefit Pension Plan is the sole limited partner of AstraZeneca-MedImmune Venture Fund.

Limited Partner Name Type Status Commitment Date Commitment Type
AstraZeneca Defined Benefit Pension Plan Current Original
To view AstraZeneca-MedImmune Venture Fund’s complete limited partners history, request access »

AstraZeneca-MedImmune Venture Fund Returns Data

The below charts are illustrative of the type of graphical data available to our clients and do not represent live data.

IRR (%)

 

DPI (x)

 

RVPI (x)

 

TVPI (x)

 

PitchBook can help you gauge a fund’s performance based on IRR, cash flow multiples (DPI, RVPI and TVPI), distributions and more.

Request a free trial

AstraZeneca-MedImmune Venture Fund FAQs

  • What is AstraZeneca-MedImmune Venture Fund?

    AstraZeneca-MedImmune Venture Fund was a venture capital fund managed by MedImmune Ventures.

  • Who manages AstraZeneca-MedImmune Venture Fund?

    AstraZeneca-MedImmune Venture Fund is managed by MedImmune Ventures.

  • Where is AstraZeneca-MedImmune Venture Fund domiciled?

    AstraZeneca-MedImmune Venture Fund is domiciled in United States.

  • What is AstraZeneca-MedImmune Venture Fund's size?

    AstraZeneca-MedImmune Venture Fund has a size of $400M.

  • What type of fund is AstraZeneca-MedImmune Venture Fund?

    The fund type of AstraZeneca-MedImmune Venture Fund is Venture.

  • What is the status of AstraZeneca-MedImmune Venture Fund?

    AstraZeneca-MedImmune Venture Fund is liquidated.

  • What has AstraZeneca-MedImmune Venture Fund invested in?

    AstraZeneca-MedImmune Venture Fund has made numerous investments in companies like G1 Therapeutics, Astria Therapeutics, and Inotek Pharmaceuticals within the Drug Discovery industry.

  • What has AstraZeneca-MedImmune Venture Fund invested in recently?

    AstraZeneca-MedImmune Venture Fund's latest investment was on 01-Jul-2016 in G1 Therapeutics, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process